Preclinical development of an oral anti- Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis (2019)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aau2086

PubMed Identifier: 30867321

Publication URI: http://europepmc.org/abstract/MED/30867321

Type: Journal Article/Review

Parent Publication: Science Translational Medicine

Issue: 483

ISSN: 1946-6234